劲牌营收预增9.6%夯实百亿级地位 吴少勋“保健+草本”布局冲破增长藩篱

Core Viewpoint - The company, Jinpai, is solidifying its position as a billion-level enterprise, with a projected revenue of 13.7 billion yuan in 2025, marking a 9.6% year-on-year growth, and its core brand, Jinjiu, expected to grow over 20% [1][5]. Group 1: Company Performance - Jinpai has been stagnant in revenue growth for several years before launching the herbal liquor, Maopu, to rejuvenate its product line and appeal to younger consumers [2][9]. - The company has successfully attracted 9 million young users aged 18-30 and 4 million female users in the past two years, leveraging a strategy focused on "light drinking" and social engagement [5]. - Jinpai's revenue growth is notable amidst a broader industry downturn characterized by policy adjustments and shifting consumer preferences [4][13]. Group 2: Product Development - The company has diversified its product offerings into three main segments: health liquor, herbal liquor, and traditional Chinese medicine, with a focus on health-oriented products [4]. - The Maopu herbal liquor has undergone a quality upgrade, utilizing aged spirits and herbal essences, and has received accolades, including a gold award at the WSEAC 2025 [10]. - Jinpai invests over 3% of its sales revenue into research and development, resulting in 266 authorized patents, with a focus on enhancing product quality and innovation [11]. Group 3: Quality Assurance and Standards - Jinpai has established a quality information platform for traceability and has set up 54 direct supply bases for medicinal materials, ensuring rigorous quality control [12]. - The company has developed over 6,800 enterprise standards, many of which exceed national standards, and is leading the formulation of new national standards for liquor quality [11][12]. - Jinpai successfully passed the review for the National Quality Award, indicating its commitment to maintaining high-quality standards [12]. Group 4: Future Goals - The company has set ambitious long-term sales targets, aiming for over 80 billion yuan by 2042 and over 100 billion yuan by 2053 [12].